RSNA 2020: Addressing Healthcare Disparities and Access to Care
Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Work has been ongoing for years to decrease the presence and impact of disparities throughout healthcare, including in radiology. But, problems still exist, and there are new challenges on the horizon that could make it more difficult for radiologists to make it easier for patients to get the imaging services they need.
During this year's Radiological Society of North America (RSNA) annual meeting, Richard Heller, M.D., associate chief medical officer and national director of pediatric radiology with Radiology Partners, and Lucy Spalluto, M.D., associate professor of radiology and radiological sciences at Vanderbilt University School of Medicine, participated in a session dedicated to addressing the continued existence of health disparities.
In this episode of The Reading Room, they talk with Diagnostic Imaging about the underlying factors that result in healthcare disparities, as well as the challenges providers and facilities face to improving access to care.
For additional RSNA coverage, click here.
Burnout in Radiology: Key Risk Factors and Promising Solutions
June 9th 2025Recognizing the daunting combination of increasing imaging volume and workforce shortages, these authors discuss key risk factors contributing to burnout and moral injury in radiology, and potential solutions to help preserve well-being among radiologists.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
